A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0843
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer ; volume:80 ; number:6 ; day:25 ; month:10 ; year:2017 ; pages:1197-1207 ; date:12.2017
Cancer chemotherapy and pharmacology ; 80, Heft 6 (25.10.2017), 1197-1207, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Sakai, Daisuke
- Beteiligte Personen und Organisationen
-
Chung, Hyun Cheol
Oh, Do-Youn
Park, Se Hoon
Kadowaki, Shigenori
Kim, Yeul Hong
Tsuji, Akihito
Komatsu, Yoshito
Kang, Yoon-Koo
Uenaka, Kazunori
Wijayawardana, Sameera R.
Wacheck, Volker
Wang, Xuejing
Yamamura, Ayuko
Doi, Toshihiko
SpringerLink (Online service)
- DOI
-
10.1007/s00280-017-3445-z
- URN
-
urn:nbn:de:1111-201801134375
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sakai, Daisuke
- Chung, Hyun Cheol
- Oh, Do-Youn
- Park, Se Hoon
- Kadowaki, Shigenori
- Kim, Yeul Hong
- Tsuji, Akihito
- Komatsu, Yoshito
- Kang, Yoon-Koo
- Uenaka, Kazunori
- Wijayawardana, Sameera R.
- Wacheck, Volker
- Wang, Xuejing
- Yamamura, Ayuko
- Doi, Toshihiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Short-Term Safety Evaluation of a Multi-Pressure Dial: A Prospective, Open-label, Non-randomized Study
Combined exercise and nutrition intervention for older women with spinal sarcopenia: an open-label single-arm trial
Effects of Ivabradine on Myocardial Perfusion in Chronic Angina: A Prospective, Preliminary, Open-Label, Single-Arm Study
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Short-Term Safety Evaluation of a Multi-Pressure Dial: A Prospective, Open-label, Non-randomized Study
Combined exercise and nutrition intervention for older women with spinal sarcopenia: an open-label single-arm trial
Effects of Ivabradine on Myocardial Perfusion in Chronic Angina: A Prospective, Preliminary, Open-Label, Single-Arm Study
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Short-Term Safety Evaluation of a Multi-Pressure Dial: A Prospective, Open-label, Non-randomized Study
Combined exercise and nutrition intervention for older women with spinal sarcopenia: an open-label single-arm trial
Effects of Ivabradine on Myocardial Perfusion in Chronic Angina: A Prospective, Preliminary, Open-Label, Single-Arm Study
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer